Dyne Therapeutics, Inc. · NASDAQ:DYN
T. Rowe Price Investment Management, Inc. reported a 10.70% stake in Dyne Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 8, 2026
T. Rowe Price Investment Management, Inc. reported a 10.70% stake in Dyne Therapeutics, Inc., 17,540,089 shares, as a passive investor on Dec 31, 2025. Filed Jan 8, 2026 (Schedule 13G).
- Stake
- 10.70%
- Shares
- 17,540,089
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10.70% | 17,540,089 |
Source
Related
- Dyne Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 15, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Mar 6, 2026
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026